PropertyValue
?:abstract
  • Despite the high number of victims of COVID-19, tuberculosis (TB) remains as the leading cause of death among infectious diseases worldwide. Since the beginning of the pandemic, there is an increasing number of studies trying to elucidate the interactions between Mycobacterium tuberculosis and SARS-CoV-2. The first case reports point to a worsening of respiratory symptoms in co-infected TB/COVID-19 individuals. However, data from the cohort studies has shown some conflicting results. This study proposes to conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system. From an immunological perspective, the TB/COVID-19 co-infection has the potential to generate a \'perfect storm\'. The disorders induced by each pathogen to the immune modulation tend to induce an unbalanced inflammatory response, which can promote the progression and worsening of both diseases. Understanding the nature of the interactions between M. tuberculosis and SARS-CoV-2 will be crucial for the development of therapeutic strategies against co-infection.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.tube.2020.102020
?:journal
  • Tuberculosis_(Edinb)
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/f3c3368d4e6728f5ea7ba7a27c06f0a7ace05164.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7669479.xml.json
?:pmcid
?:pmid
?:pmid
  • 33246269.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Pathology of TB/COVID-19 Co-Infection: The phantom menace
?:type
?:year
  • 2020-11-17

Metadata

Anon_0  
expand all